Upgrade to SI Premium - Free Trial

Merck (MRK), Eisai Co. Granted FDA Breakthrough Therapy Designation for LENVIMA

July 31, 2018 5:46 AM
Eisai Co., Ltd. and Merck & Co., Inc. Kenilworth, N.J., U.S.A. (NYSE: MRK), known as MSD outside the United States ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA Management Comments

Next Articles